Skip to main content
Clinical Trials/EUCTR2020-005956-39-FR
EUCTR2020-005956-39-FRActive, not recruitingPhase 1

Treatment of pediatric Post-traumatic Stress Disorder with memory reactivation under the influence of propranolol: A randomized placebo-controlled trial - PPP

CHU Toulouse0 sites92 target enrollmentStarted: January 22, 2021Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
92

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • -Children aged 7-12 years
  • -CPTS-RI total score =40
  • -Primary diagnosis of PTSD (6 months or more after the traumatic event)
  • -Affiliation to a social security scheme
  • -Written consent signed by the parents/holders of parental authority and the investigator
  • -Acceptance of the protocol by the child
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 92
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • -Age<7 years or =13 years
  • -Child or parents that don’t have a good understanding of the French language according to investigator's opinion
  • - Children whose parents have been deprived of their authority
  • -Contraindication to propranolol (cardiogenic shock, sinus bradycardia, hypotension (< fifth percentile oscillometric or <2SD) (Banker et al., 2016)., greater than first-degree heart block, heart failure, bronchial asthma and hypersensitivity to propranolol hydrochloride)
  • -Heart Rate/HR<50 bpm
  • -Concurrent medication with possible interactions with propranolol
  • --Concurrent psychotropic drugs that have been shown to be effective in improving symptoms of PTSD
  • -Concurrent psychotherapy (>1 stuctured session/month declared by the clinician who follows the child)
  • -Current active psychosis, anorexia nervosa, bulimia nervosa, binge-eating disorder, attention-deficit hyperactivity disorder, autism spectrum disorder
  • -Pregnancy

Investigators

Sponsor
CHU Toulouse

Similar Trials